ProKidney Corp. (US: PROK) — Healthcare · Share Price, Chart & Market Data
About: ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.95 (+0.52%)
PROKProKidney Corp.
Loading watchlist status…
Trade PROK now
ProKidney Corp. share price
PROK price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 2:52 pm GMT+0
PROK price performance
-6.699%
5D
21.875%
1M
-12.556%
YTD
89.32%
1Y
PROK price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 2:52 pm GMT+0
PROK details
PROK Market Signals